3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- The Gut Microbiome May Unlock New Treatment Paradigms For Neurological Diseases – Axial Therapeutics
- Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
- Behavioral Signals Recognized As Emotion AI Leader By Gartner In Multiple 2023 Hype Cycle Reports
- MemVerge and SK hynix Accelerate Memory Pooling and Sharing Software Development with CXL Flight Simulator
- Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Pancreatic Cancer